Skip to main content
Clinical Trials/EUCTR2016-003986-25-ES
EUCTR2016-003986-25-ES
Active, not recruiting
Phase 1

Impact of self-measurement of blood pressure and self-adjustment of antihypertensive medication in the control of hypertension and adherence to treatment. A pragmatic, randomized, controlled clinical trial (ADAMPA Study)

Instituto de Investigación Sanitaria INCLIVA0 sites458 target enrollmentMarch 17, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Arterial hypertension
Sponsor
Instituto de Investigación Sanitaria INCLIVA
Enrollment
458
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 17, 2017
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Instituto de Investigación Sanitaria INCLIVA

Eligibility Criteria

Inclusion Criteria

  • \- 40 years or older
  • \- have a diagnosis of hypertension of any origin
  • \- have a TAS\> 145 or TAD\> 90 mm Hg on the baseline examination
  • \- voluntarily agree to participate in the study and sign the corresponding informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 158
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 300

Exclusion Criteria

  • \- inability to self\-care of their blood pressure, understanding, performing and / or self\-adjusting of medication by the patient, including dementia or significant cognitive impairment at the discretion of the investigator performing the recruitment
  • \- history of orthostatic hypotension (fall\> 20 mm Hg in systolic arterial tension after the orthostatic position)
  • \- have a blood pressure\> 200 or diastolic blood pressure\> 100 mm Hg at baseline
  • \- being on treatment with more than 4 antihypertensive drugs
  • \- be included in another high blood pressure study or in a clinical trial
  • \- presence of tremor or neurological disease that makes it difficult to perform AMPA
  • \- presence of arrhythmia
  • \- presence of terminal illness
  • \- chronic incapacitation to leave your home
  • \- have had an acute cardiovascular event in the last 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials